EPSRC logo

Details of Grant 

EPSRC Reference: GR/S60389/01
Title: Radiocopper complexes for imaging & treatment of hypoxic tissues
Principal Investigator: Blower, Professor P
Other Investigators:
Lloyd, Dr D Marsden, Professor P
Researcher Co-Investigators:
Project Partners:
Royal Free & University College Medical Washington University in St Louis
Department: Sch of Biosciences
Organisation: University of Kent
Scheme: Standard Research (Pre-FEC)
Starts: 01 June 2004 Ends: 31 March 2006 Value (£): 347,906
EPSRC Research Topic Classifications:
Biological & Medicinal Chem. Drug Formulation & Delivery
Medical science & disease
EPSRC Industrial Sector Classifications:
Pharmaceuticals and Biotechnology
Related Grants:
Panel History:  
Summary on Grant Application Form
Shortage of oxygen (hypoxia) in tissues occurs in many diseases. It is one of the main causes of cancer treatment failure. A reliable imaging procedure to detect hypoxia, such as PET, would represent a major clinical advance, helping to locate disease within the body, plan treatments, and predict outcomes in oncology, cardiology and neurology. These different clinical contexts will require hypoxia targeting agents tuned to have subtly different in vivo properties, targeting different oxygen levels. In this project we will provide these imaging agents by modifying the prototype agent CuATSM, which is taken up specifically in hypoxic cells, to develop a range of radioactive imaging agents individually optimised for the different uses. We will also develop a new type of treatment for use alongside conventional therapies, in which hypoxia-targeted radioisotopes kill resistant hypoxic cancer cells. To achieve this, a mufti-disciplinary effort is planned at a cost of approximately 300k, to develop production of the radioisotope Cu-64 (radiochemistry, St Thomas' Hospital, London), synthesise a large number of complexes from which to choose those with the best properties (synthetic chemistry, University of Kent), and measure the relevant properties in cultured cancer cells (analytical chemistry and radiobiology, University of Kent). The new products will be tested in vivo by collaboration with groups at Royal Free Hospital. London. and Washington University. St. Louis. USA.
Key Findings
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Potential use in non-academic contexts
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Impacts
Description This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Summary
Date Materialised
Sectors submitted by the Researcher
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Project URL:  
Further Information:  
Organisation Website: http://www.kent.ac.uk